The Medical Letter on Drugs and Therapeutics
FROM
ISSUE 1159
ISSUE 1159
June 23, 2003
Issue 1159
Subscribers: Log in to read full issue. Not a subscriber? Subscribe or purchase issue.
Enfuvirtide (Fuzeon) for HIV infection
June 23, 2003 (Issue: 1159)
Enfuvirtide (T-20; Fuzeon Trimeris/Roche), the first in a new class of HIV drugs known as fusion inhibitors, has received accelerated approval from the FDA for use with other antiretrovirals in adults and children with viral replication despite...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.